Design
Editorial
Answers are grounded in this paper and cite their sources.
This editorial summarizes recent evidence across multiple cardiovascular domains, highlighting that even light physical activity is better than being sedentary for coronary patients, while vigorous activity provides additional benefits.
Significant residual risk in patients with atherosclerotic cardiovascular disease (CVD) also remains with conventional risk factor control.1 Thus, alternative strategies to combat this unmet need have been considered as a priority. In the present issue, a number of non-traditional determinants of cardiometabolic health are reviewed, such as poor diet quality, ambient air pollution and noise, sleep deprivation, psychosocial stress and unhealthy body composition. For example, the authors have proposed that shifting the focus from body mass to body composition and cardiorespiratory fitness, from nutrient- and calorie-based approaches to food-based, calorie-unrestricted dietary recommendations and addressing exposure to novel lifestyle risk factors through public health interventions might result in more feasible lifestyle guidance. Furthermore, a combined approach may improve long-term adherence and ameliorate prognosis, achieving cumulative benefit. Finally, the proposed lifestyle changes may cause a set of phenotypic adaptations that shift tissue crosstalk from a proinflammatory milieu, conducive for high-risk atherosclerosis, to an anti-atherogenic milieu. The latest American Heart Association (AHA) hypertension guidelines have lowered the threshold of stage 1 hypertension to 130/80 mmHg but have also stimulated intense debate.2 In this issue the association of the new AHA criteria with all-cause and CVD mortality was evaluated based on the pooled data from three prospective Chinese cohorts. It was observed that there was a significant association between stage 1 hypertension and an increased risk of mortality due to CVD. Importantly, 27.4% of CVD deaths could be prevented if stage 1 hypertension was treated among adults when younger. However, as the authors acknowledge, the exact proportion of patients that would require antihypertensive medications according to the new AHA guidelines could not be calculated in this setting due to the lack of available data on the baseline cardiovascular risk score. For individuals younger than 65 years of age and without pre-existing CVD, comprehensive management of blood pressure to less than 130/80 mmHg (by way of lifestyle modifications and home blood pressure monitoring) may contribute to the prevention of CVD mortality, but lowering of the blood pressure threshold may also increase the risks of overdiagnosis and overtreatment, with no definite data on cost-effectiveness.3 Blood pressure values are characterised by marked fluctuations occurring over time, a phenomenon referred to as blood pressure variability (BPV). BPV differs between individuals and is more pronounced at higher blood pressure levels. A large number of observational studies and their meta-analyses have suggested that BPV might independently contribute to prognosis in hypertension, but the clinical importance of this contribution is still a matter of debate. A retrospective analysis of Dublin Outcome Study data, which included 9154 untreated individuals assessed for hypertension, observed that diastolic short-term BPV independently predicts cardiovascular mortality in hypertensive subjects at all ages, while systolic BPV seems to be a particularly strong predictor in young adults only. In young subjects, increased systolic BPV might reflect an impaired autonomic control of circulation: reduced sensitivity of arterial baroreflex may contribute to mortality by increasing the risk of sudden cardiac death.4 The TeleRehabilitation in Coronary Heart Disease (TRiCH) study is a randomised controlled clinical trial designed to investigate the long-term effect of a home-based exercise intervention with telemonitoring guidance on exercise capacity in coronary artery disease (CAD) patients after discharge from a phase II cardiac rehabilitation programme. Here, a small population of 90 CAD patients (80 men, average age 63 years) were randomly assigned to three months of home-based (n = 30), centre-based (n = 30) or a control group (n = 30) on a 1:1:1 basis after completion of their phase II ambulatory cardiac rehabilitation programme: the results are quite interesting since exercise capacity and secondary outcomes were preserved in all three groups, irrespective of the intervention. The persisting high level of physical activity is indeed encouraging and is in some contrast to the study by Harrison and Doherty in which less than 40% of the CVD patients reported maintaining recommended physical activity levels of over 150 min per week.5 However probably an intervention longer than just three months is necessary to find a significant benefit of exercise capacity in this setting of patients. The patients with adult congenital heart disease (ACHD) are a growing group of individuals, often characterised by the occurrence of debilitating psycho-affective disorders, of which depression and anxiety are dominant. Symptoms of depression and anxiety are considered a general risk factor for atherosclerotic disease,6 reduced quality of life and cardiac ischaemic events. However, there is still uncertainty regarding the benefit of any specific psychological intervention offered to reduce depressive symptoms and cardiac morbidity.7 Here, a diagnostic evaluation of well-known psychometric screening instruments for depression in adults with ACHD is presented. These instruments were favourably blinded compared to gold standard diagnostic tools. The authors correctly point out that the specific clinical cut-offs for depressive disorder in ACHD are in need of external validation, since the study was based on a single site and the sample size did not allow for robust resampling. The foetal alcohol syndrome (FAS) was first described by Jones and Smith and included craniofacial abnormalities, growth deficiencies, central nervous systems dysfunctions and neuro-behavioural disabilities.8 The prevalence of congenital heart diseases (CHDs) among FAS births is reported to be as high as 70%, confirming their significant association with prenatal drinking. The pathophysiological basis consists of genetic and epigenetic factors or direct toxicity to the embryonic neural crest cells, which play a major role in valvular development and heart septation. In contrast with previous inconclusive studies, the meta-analysis presented here (52 studies involving 41,747 CHD cases) shows that both maternal and paternal alcohol exposure were significantly associated with risk of total CHDs in offspring. Additionally, a nonlinear dose-response relationship between parental alcohol exposure and risk of total CHDs was observed. Regular physical activity and exercise are recommended in all individuals and in high-risk patients (such as CAD) in particular.9 The modalities of the exercise intervention are still poorly investigated.10 Here, in a large population of patients with stable CAD enrolled in the CLARIFY registry, it was confirmed that various levels of physical activity are associated with a favourable outcome in terms of all-cause mortality and cardiovascular mortality. Not unexpectedly, the determinants of physical activity levels were associated with sex, race/ethnicity, employment status, education level, smoking history, family history of CAD, dyslipidaemia and various comorbidities. More interestingly, vigorous activity, but less than two times/week, was associated with better outcomes superior to light activity, and light activity is associated with better outcomes than sedentary activity. However, a higher frequency (>2 times/week) of vigorous physical activity was not associated with greater clinical benefit. The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article. The author(s) received no financial support for the research, authorship and/or publication of this article.
No takes yet. Share an insight, caveat, or question.
Massimo Piepoli (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: